【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Key buying criteria
PART 05: Disease overview
• Introduction
• Risk factors
• Diagnosis
• Management
• Epidemiology
• Economic burden
PART 06: Pipeline portfolio
PART 07: Market landscape
• Global diabetes drugs market
• Global type 2 diabetes drugs market
• Five forces analysis
PART 08: Market segmentation by drug class
PART 09: Insulin
• Product portfolio
• Global insulin market
PART 10: DPP-4 inhibitors
• Market overview
• Market size and forecast
PART 11: GLP-1 receptor agonists
• Market overview
• Market size and forecast
PART 12: SGLT-2 inhibitors
• Market overview
• Market size and forecast
PART 13: Geographical segmentation
• Global type 2 diabetes drugs market by geographical segmentation 2015-2020
• Type 2 diabetes drugs market in Americas
• Type 2 diabetes drugs market in EMEA
• Type 2 diabetes drugs market in APAC
PART 14: Market drivers
• Rising prevalence of diabetes
• Rise in obesity rates
• Growing older population
• Unmet medical needs
• Stringent regulatory guidelines for biosimilar drugs
PART 15: Impact of drivers
PART 16: Market challenges
• Low diagnosis rate
• Rising concerns in scientific community
• Gaps in national-level diabetes management plans
• Poor storage conditions and distribution policies for insulin
• Fierce market competition
PART 17: Impact of drivers and challenges
PART 18: Market trends
• Increase in awareness of diabetes
• Increase in academia-industry collaboration
• Rising price of diabetes drugs
• Increase in R&D
PART 19: Vendor landscape
• Competitive scenario
• Market analysis 2015
• Novo Nordisk
• Sanofi
• Merck
• Eli Lilly
• AstraZeneca
• Other prominent vendors
PART 20: Appendix0
• List of abbreviations
PART 21: Explore Technavio1
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for type 2 diabetes drugs
Exhibit 03: Line of therapy for type 2 diabetes
Exhibit 04: Pipeline portfolio: Global type 2 diabetes drugs market
Exhibit 05: Global diabetes drugs market by prevalence based on type of disease 2015
Exhibit 06: Top selling diabetes drugs based on sales 2014 ($ billions)
Exhibit 07: Market share of global diabetes drugs in global pharmaceutical drugs market 2015
Exhibit 08: Global diabetes drugs market 2015-2020 ($ billions)
Exhibit 09: Market share analysis of vendors in global diabetes drugs market
Exhibit 10: Global type 2 diabetes drugs market 2015-2020 ($ billions)
Exhibit 11: Five forces analysis
Exhibit 12: Segmentation of global type 2 diabetes drugs market by drug class
Exhibit 13: Segmentation of global type 2 diabetes drugs market by drug class 2015
Exhibit 14: Comparison of different classes of type 2 diabetes drugs
Exhibit 15: Global human insulin market 2015-2020 ($ billions)
Exhibit 16: Global insulin market revenues by type of diabetes 2015
Exhibit 17: Segmentation of global insulin market based by drug class 2015
Exhibit 18: Segmentation of global insulin market by geography 2015
Exhibit 19: DPP-4 inhibitor drugs approved in market
Exhibit 20: Global DPP-4 inhibitors drugs market for type 2 diabetes 2015-2020 ($ billions)
Exhibit 21: GLP-1 receptor agonists approved in market
Exhibit 22: Global GLP-1 receptor agonists drugs market for type 2 diabetes 2015-2020 ($ billions)
Exhibit 23: Segmentation of global GLP-1 receptor agonists drugs market for type 2 diabetes by geography 2015
Exhibit 24: Approved SGLT-2 inhibitor drugs
Exhibit 25: Global SGLT-2 inhibitors market for type 2 diabetes 2015-2020 ($ billions)
Exhibit 26: Segmentation of global type 2 diabetes drugs market by geography 2015
Exhibit 27: Global type 2 diabetes drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 28: Percentage share of global type 2 diabetes drugs market by geography 2015-2020
Exhibit 29: Type 2 diabetes drugs market in Americas 2015-2020 ($ billions)
Exhibit 30: Segmentation of type 2 diabetes drugs market in Americas by country 2015
Exhibit 31: Type 2 diabetes drugs market in US 2015-2020 ($ billions)
Exhibit 32: Type 2 diabetes drugs market in Brazil 2015-2020 ($ billions)
Exhibit 33: Type 2 diabetes drugs market in EMEA 2015-2020 ($ billions)
Exhibit 34: Type 2 diabetes drugs market in APAC 2015-2020 ($ billions)
Exhibit 35: Segmentation of type 2 diabetes drugs market in APAC by country 2015
Exhibit 36: Global type 2 diabetes drugs market: YoY growth and revenue based on geography 2015-2020
Exhibit 37: Impact of drivers
Exhibit 38: Impact of drivers and challenges
Exhibit 39: YOY revenues from sales of top seven products in global type 2 diabetes drugs market 2012-2014 ($ billions)
Exhibit 40: Novo Nordisk: Business segmentation by revenue 2015
Exhibit 41: Novo Nordisk: R&D expenditure 2015
Exhibit 42: Novo Nordisk: Key product offerings in global type 2 diabetes drugs market
Exhibit 43: Novo Nordisk: YoY revenue and growth rate generated from net product sales of human insulins 2012-2015 ($ billions)
Exhibit 44: Novo Nordisk: YoY revenue and growth rate generated from net product sales of Levemir 2012-2015 ($ billions)
Exhibit 45: Novo Nordisk: YoY revenue and growth rate of NovoRapid/NovoLog 2012-2015 ($ billions)
Exhibit 46: Novo Nordisk: Revenues of NovoRapid/NovoLog by geography 2015
Exhibit 47: Novo Nordisk: YoY revenue and growth rate of NovoMix/NovoLog Mix 2012-2015 ($ billions)
Exhibit 48: Novo Nordisk: Revenues of NovoMix/NovoLog Mix by geography 2015
Exhibit 49: Novo Nordisk: YOY revenue and growth rate generated from net product sales of new-generation insulins 2013-2015 ($ millions)
Exhibit 50: Novo Nordisk: YoY revenue and growth rate of Victoza 2012-2015 ($ billions)
Exhibit 51: Novo Nordisk: YoY revenue and growth rate of Victoza in US 2013-2015 ($ billions)
Exhibit 52: Novo Nordisk: YoY revenue and growth rate of Victoza in Europe 2013-2015 ($ billions)
Exhibit 53: Novo Nordisk: YoY revenue and growth rate of Novonorm, Prandin, and Prandimet 2012-2014 ($ billions)
Exhibit 54: Novo Nordisk: Key takeaways
Exhibit 55: Sanofi: Business segmentation by revenue 2015
Exhibit 56: Sanofi: Key product offerings in global type 2 diabetes drugs market
Exhibit 57: Sanofi: YoY revenue and growth rate of Lantus 2012-2015 ($ billions)
Exhibit 58: Sanofi: Geographical segmentation of Lantus by revenue 2015
Exhibit 59: Sanofi: YoY revenue and growth rate of Amaryl 2012-2015 ($ millions)
Exhibit 60: Sanofi: Geographical segmentation of Amaryl by revenue 2015
Exhibit 61: Sanofi: YoY revenue and growth rate of Apidra 2012-2015 ($ millions)
Exhibit 62: Sanofi: Geographical segmentation of Toujeo by revenue 2015
Exhibit 63: Sanofi: YoY revenue and growth rate of Insuman 2012-2015 ($ millions)
Exhibit 64: Sanofi: YoY revenue and growth rate of Lyxumia 2013-2015 ($ millions)
Exhibit 65: Sanofi: Key takeaways
Exhibit 66: Merck: Business segmentation by revenue 2015
Exhibit 67: Merck: Diabetes segmentation by revenue 2015
Exhibit 68: Merck: Key product offerings in global type 2 diabetes drugs market
Exhibit 69: Merck: YoY revenue and growth rate of Janumet 2012-2015 ($ billions)
Exhibit 70: Merck: YoY revenue and growth rate of Januvia from 2012-2015 ($ billions)
Exhibit 71: Merck: Key takeaways0
Exhibit 72: Eli Lilly: Key product offerings in global type 2 diabetes drugs market1
Exhibit 73: Eli Lilly: YoY revenue and growth rate of Humalog 2012-2015 ($ billions)1
Exhibit 74: Eli Lilly: YoY revenue and growth rate of Humalog in US 2013-2015 ($ billions)2
Exhibit 75: Eli Lilly: YoY revenue and growth rate of Humalog in ROW 2013-2015 ($ billions)2
Exhibit 76: Eli Lilly: YoY revenue and growth rate of Humulin 2012-2015 ($ billions)3
Exhibit 77: Eli Lilly: YoY revenue and growth rate of Humulin in US 2013-2015 ($ millions)3
Exhibit 78: Eli Lilly: YoY revenue and growth rate of Humulin in ROW 2013-2015 ($ millions)3
Exhibit 79: Eli Lilly: YoY revenue and growth rate of Tradjenta 2012-2015 ($ millions)4
Exhibit 80: Eli Lilly: YoY revenue of Trulicity 2014-2015 ($ millions)5
Exhibit 81: Eli Lilly: Trulicity geographical segmentation by revenue 20155
Exhibit 82: Eli Lilly: Key takeaways7
Exhibit 83: AstraZeneca: Key product offerings in global type 2 diabetes drugs market9
Exhibit 84: AstraZeneca: Farxiga/Forxiga geographical segmentation by revenues 20159
Exhibit 85: AstraZeneca: YoY revenues and growth rate of Byetta 2012-2015 ($ millions)0
Exhibit 86: AstraZeneca: YoY revenues and growth rate of Byetta in US ($ millions)0
Exhibit 87: AstraZeneca: YoY revenues and growth rate of Bydureon 2012-2015 ($ millions)1
Exhibit 88: AstraZeneca: YoY revenues and growth rate of Bydureon in US ($ millions)1
Exhibit 89: AstraZeneca: YoY revenues and growth rate of Onglyza 2012-2015 ($ millions)2
Exhibit 90: AstraZeneca: YoY revenues and growth rate of Onglyza/Kombiglyze XR/Komboglyze in US ($ millions)2
Exhibit 91: AstraZeneca: Key takeaways
【レポート販売概要】
■ タイトル：2型糖尿病治療薬の世界市場：インスリン、DPP-4阻害薬、GLP-1受容体作動薬、 SGLT-2阻害薬■ 英文：Global Type 2 Diabetes Market 2016-2020
■ 発行日：2016年3月23日
■ 調査会社：Technavio
■ 商品コード：IRTNTR8779
■ 調査対象地域：世界
- がんワクチンの世界市場：予防ワクチン、治療ワクチンAbout Cancer Vaccines Cancer vaccines are biological preparations that stimulate or strengthen a person’s immune system against cancer. Cancer vaccines are usually administered intravenously. They can be used in both adults and children. The vaccines can be broadly classified into two: prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas thera …
- OLED照明の世界市場2015-2022A year ago the outlook for OLED lighting seemed to brighten a bit, anticipating that new capacity build-outs and continued development would enable higher outputs and lower costs, and finally start to unlock broad market demand. Unfortunately these efforts largely haven't panned out: LG Chem has pushed out its planned expansion, Konica Minolta did ramp but we believe with disappointing results so …
- 耐火材料のグローバル市場動向（2014-2018）About Refractory Materials Refractory materials are used in the refractory lining of furnaces, kilns, incinerators, and reactors. These These materials have a high melting point (greater than 2768 degrees Fahrenheit). They are subjected to various conditions such as high temperature, abrasion and chemical corrosion, slag attack, and chemical reactions when they are used in refractory linings. Henc …
- スマートコーヒーメーカーの世界市場2017-2021About Smart Coffee MakerA coffee maker is a countertop appliance that brews hot coffee. Smart coffee makers are the part of automatic coffee brewing machines. Smart coffee makers are enabled with Wi-Fi and Bluetooth and can be operated by using an app on a smartphone. These smart coffee makers can be used from distant locations and offer the benefit of remotely controlling the device through smart …
- 世界の食品生産市場におけるバイオテクノロジー動向（2014-2024）The biotechnology in food production market will reach US$101.96bn in 2014. Meeting rising global food needs will demand another era of widespread adoption of innovative, science-based biotechnologies in food production that consider environmental and ecological issues, nutrient deficiencies and other more complex issues. The food system already looks different than it was 20 or 30 years ago: peop …
- ブラジルの発電市場2016：市場動向、制度、競争状況Brazil Power Market Outlook to 2030, Update 2016 - Market Trends, Regulations, and Competitive Landscape Summary This report elaborates Brazil's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Brazil power market’s regulatory structure, import and export trends, competitive landscape, and power projec …
- フェイシャルエステティックの世界市場2018-2022About facial aesthetics Facial aesthetics aid in removing wrinkles and improving the aesthetic appeal of the face. Facial aesthetic products are injected under the skin or lips to plump up the tissues and restore the collagen lost due to aging. Technavio’s analysts forecast the Global facial aesthetics market to grow at a CAGR of 8.05% during the period 2018-2022. Covered in this report The report …
- アフェレーシスの世界市場：血漿交換、血小板フェレーシス、赤血球アフェレーシス、白血球除去療法、循環光療法Apheresis is an essential tool in modern medical practices in the blood industry. It is a process in which the blood of a donor/patient is passed through a medical device, which separates one or more components of the blood and returns the remaining with or without extracorporeal treatment or replacement of separated components. The global apheresis market is expected to reach USD 2.5 billion by 2 …
- アナログIC（集積回路）の世界市場2016-2020About Analog IC Analog ICs are used in most electronic devices due to their power management function. Analog ICs are very small in size and are developed on a semiconductor material. The voltage and current levels vary. These ICs consist of logic components that allow them to connect and communicate with the microprocessors of the electronic devices in which they are embedded. Technavio’s analyst …
- 光学イメージング技術の世界市場：ハイパースペクトル画像、近赤外線分光法、光音響トモグラフィAbout Optical Imaging Optical imaging is a non-invasive technique and is helpful in diagnosing the body by using the visible light and non- ionization radiation. Non-ionization radiation includes visible, UV, and infrared light, which reduces patient exposure to harmful radiation and generates images by exciting electrons. Optical imaging can be combined with MRI and X-rays to provide the enhanced …
- Worldwide Cellular Networks Revenue ReportThis report and the associated excel database tracks country level revenue and ARPU figures from over 162 countries and provides long term forecasts up to 2015. Numerical results in the report are presented in a comprehensible graphical style with granularity levels varying from a global level to a specific regions and countries. Figures from the report can be used to track investment opportunitie …
- Alcon, Inc.：市場シェア分析Alcon, Inc. Market Share Analysis Summary GlobalData’s new report, “Alcon, Inc. Market Share Analysis” provides in-depth information on Alcon, Inc.’s market position in the different medical equipment markets it operates in. The report provides Alcon, Inc. market share information in six key market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Refractive …
- sfRowasa(潰瘍性大腸炎)：市場分析と予測（～2022）sfRowasa (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affectin …
- Abbott Laboratories：市場シェア分析Abbott Laboratories Market Share Analysis Summary GlobalData’s new report, “Abbott Laboratories Market Share Analysis” provides in-depth information on Abbott Laboratories’s market position in the different medical equipment markets it operates in. The report provides Abbott Laboratories market share information in 10 key market categories – Interventional Cardiology, Infectious Immunology, Geneti …
- 世界の建設産業におけるポータブル発電機市場2015-2019About generators Generators are backup devices designed to provide temporary AC or DC power. They can be used as a source of backup or emergency power for residential, commercial, and industrial applications. A typical generator is powered via a fuel engine. Based on portability, generator can be segmented into portable and standby. Portable generators are the best solutions to provide AC power fo …
